Ilosone
Gastroparesis, Erythrasma, Whooping Cough + 60 more
Treatment
68 FDA approvals
20 Active Studies for Ilosone
Treatment for
Gastroparesis
What is Ilosone
Erythromycin
The Generic name of this drug
Treatment Summary
Erythromycin is an antibiotic drug used to treat various bacterial infections. It was first discovered in 1952 and belongs to a group of antibiotics called macrolides, which includes Azithromycin, Clarithromycin, and Spiramycin. It can be administered in different forms, such as intravenously, topically, or as eye drops.
Erythrocin Stearate
is the brand name
Ilosone Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erythrocin Stearate
Erythromycin
1964
261
Approved as Treatment by the FDA
Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 68 uses which include Corynebacterium Infections and Acne Vulgaris .
Corynebacterium Infections
Acne Vulgaris
Used to treat Acne Vulgaris in combination with Tretinoin
Acne Vulgaris
Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin
Urethritis
urogenital infections during pregnancy
Pertussis
treponema pallidum infection
Diphtheria
Bacterial Infections
Staphylococcus (S.) Aureus Infection
penicillins
Communicable Diseases
Conjunctivitis
Respiratory Tract Infections
Erythrasma
Postoperative Infections
Listeriosis
Corynebacterium minutissimum infection
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
Pneumonia, Mycoplasma
Whooping Cough
Bordetella Pertussis Infection
uncomplicated endocervical infection
Staphylococcal Skin Infections
Communicable Diseases
pustular lesions
Used to treat pustular lesions in combination with Avobenzone
Communicable Diseases
Bacterial Infections
Whooping Cough
Pneumonia
Listeria infection
Listeria monocytogenes infection
Acute Otitis Media caused by Haemophilus Influenzae
Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole
inflammatory papular lesions
Used to treat inflammatory papular lesions in combination with Avobenzone
Amebiasis
Common Cold
Rheumatic Fever
prophylaxis of Postoperative Infections
Communicable Diseases
prophylaxis of Rheumatic fever
Ureaplasma urethritis
penicillins
Upper Respiratory Tract Infection
Streptococcus Pneumoniae Infections
Streptococcus pyogenes
Staphylococcal Skin Infections
Urethritis
Urinary Tract Infection (UTI)
Legionella pneumophila
Primary Syphilis
Lower Respiratory Tract Infection (LRTI)
Intestinal amebiasis caused by entamoeba histolytica
Skin and skin structure infections
Corynebacterium Infections
diphtheria antitoxin
Bronchitis
Haemophilus Influenzae Infections
Used to treat Haemophilus Influenzae Infections in combination with null
Urethritis
Ureaplasma urealyticum
skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes
Whooping Cough
Chlamydia Trachomatis
patients with intolerance or contraindications to tetracycline use
Syphilis
First episode of rheumatic fever
Rheumatic Fever
Pneumococcal Infections
Sulfonamides
Effectiveness
How Ilosone Affects Patients
Erythromycin is an antibiotic that works by stopping bacteria from producing proteins. It is effective in treating some bacterial infections, but it is important to check for bacterial resistance before prescribing it. Combining erythromycin with sulfonamides is often more effective at treating Haemophilus influenzae infections than just erythromycin alone. However, Staphylococci may develop resistance to erythromycin. Pseudomembranous colitis, a serious intestinal problem, is a possible side effect of taking erythromycin. Erythromycin can also cause liver
How Ilosone works in the body
Erythromycin works to prevent bacteria from replicating. It does this by blocking a specific step in the process of protein synthesis. This step involves building the ribosomal proteins that are necessary for the bacteria to reproduce. By blocking this step, erythromycin stops bacteria from producing the proteins they need and prevents them from multiplying. This is why erythromycin is effective against a wide range of bacterial infections.
When to interrupt dosage
The proposed dose of Ilosone is contingent upon the diagnosed affliction, comprising Chlamydia Trachomatis, penicillins and Syphilis. The amount of dosage shifts as per the method of delivery (e.g. Granule, for suspension or Tablet, film coated - Oral) outlined in the table hereunder.
Condition
Dosage
Administration
Ophthalmia neonatorum (gonococcal)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Granuloma Inguinale
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Urethritis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Whooping Cough
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Syphilis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Community Acquired Pneumonia (CAP)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Communicable Diseases
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
diphtheria antitoxin
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Common Cold
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Primary Syphilis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Corynebacterium Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Endophthalmitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Gastroparesis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Conjunctivitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Respiratory Tract Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Amebiasis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Rheumatic Fever
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Granule, for suspension - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Lotion, Kit - Topical, Injection, powder, lyophilized, for solution - Intravenous, Injection, powder, lyophilized, for solution, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Powder, for solution, Powder, for solution - Oral, Powder, Capsule, delayed release pellets, Capsule, Delayed Release
Warnings
Ilosone has nine contraindications and should not be used when encountering any of the conditions presented in the following table.
Ilosone Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Erythromycin may interact with Pulse Frequency
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Ilosone.
Common Ilosone Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be increased when it is combined with Erythromycin.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Erythromycin.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Erythromycin.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Erythromycin.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Erythromycin.
Ilosone Toxicity & Overdose Risk
The lowest toxic dose of erythromycin for rats is 9272mg/kg. Overdosing on erythromycin can cause diarrhea, nausea, stomach cramps, and vomiting. If an overdose occurs, erythromycin should be stopped and any unabsorbed drug should be removed as quickly as possible. Supportive measures should also be taken. Unfortunately, this drug cannot be removed from the bloodstream through dialysis.
Ilosone Novel Uses: Which Conditions Have a Clinical Trial Featuring Ilosone?
53 active trials are currently underway to determine the effectiveness of Ilosone in managing Streptococcus pyogenes, Treponema pallidum infection and Rheumatic Fever.
Condition
Clinical Trials
Trial Phases
Acne Vulgaris
2 Actively Recruiting
Phase 1, Phase 2, Early Phase 1
Listeriosis
0 Actively Recruiting
Legionella pneumophila
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Ureaplasma urealyticum
0 Actively Recruiting
Acute Otitis Media caused by Haemophilus Influenzae
0 Actively Recruiting
Gastroparesis
15 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Early Phase 1
Acne Vulgaris
0 Actively Recruiting
Pneumococcal Infections
0 Actively Recruiting
Corynebacterium minutissimum infection
0 Actively Recruiting
Acne Vulgaris
0 Actively Recruiting
Urinary Tract Infection (UTI)
7 Actively Recruiting
Phase 1, Phase 3, Phase 4, Not Applicable, Phase 2
Urethritis
0 Actively Recruiting
Listeria monocytogenes infection
0 Actively Recruiting
Chlamydia Trachomatis
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
penicillins
1 Actively Recruiting
Phase 3
Primary Syphilis
0 Actively Recruiting
treponema pallidum infection
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
Ilosone Reviews: What are patients saying about Ilosone?
1.3
Patient Review
8/5/2008
Ilosone for Strep Throat
Patient Q&A Section about ilosone
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What bacteria is erythromycin used to treat?
"Erythromycin is used to treat infections caused by bacteria including Streptococcus, Staphylococcus, Haemophilus, and Corynebacterium genera. These bacteria typically infect the skin and upper respiratory tract."
Answered by AI
What is the generic name of ilosone?
"Erythromycin is the generic name of a medication that is used to treat bacterial infections. The medication is medically reviewed by Drugs.com, and the most recent review was conducted on March 7, 2022."
Answered by AI
What is ilosone used for?
"Erythromycin can be used to treat infections in different parts of the body, including the respiratory tract, skin, and intestines. It can also be used to prevent and treat diseases such as Legionnaire's disease, pertussis, and syphilis."
Answered by AI
What is Erythrocin for?
"The active ingredient in Erythrocin Tablets is erythromycin, which is a type of macrolide antibiotic. These tablets are used to prevent and treat infections such as throat and sinus infections, as well as chest infections such as bronchitis and pneumonia."
Answered by AI